Resources

This weekly report provides a snapshot of data on the impact of COVID-19 in residential aged care facilities nationally. The report includes data on the number of services impacted and number of staff and resident cases, as well as workforce, testing and PPE provided to affected services.

This communique summarises the meeting of the Expert Advisory Group on Genomics Australia, held on 30 November 2023.

This document contains the surveillance case definition for invasive Group A streptococcal disease (iGAS), which is nationally notifiable within Australia. State and territory health departments use this definition to decide whether to notify us of a case.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 19 September 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 22 September 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 6 October 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 17 October 2023.

Government Response to the Senate Community Affairs Legislation Committee’s report on the Aged Care and Other Legislation Amendment (Royal Commission Response No. 2) Bill 2021. This Response details the Department’s response to Recommendation 2 of the Report.

An update from the Council of Elders after their meetings on 23 and 24 November 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 27 October 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 10 November 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 14 November 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 1 December 2023.
.

The meeting of the National Aged Care Advisory Council was held on 16 November 2023.

The Health Technology Assessment (HTA) Policy and Methods Review (Review) Reference Committee (Committee) met by video conference on 14 December 2023.

The third meeting of the National Nursing Workforce Strategy Advisory Group (SAG) was held on 1 December 2023.

The HIV Taskforce Report provides advice to the Australian Government on HIV prevention, testing, treatment, awareness raising, decriminalisation, destigmatisation and partnership.

Publication of public consultation summary report for the amendments to the International Health Regulations (2005) and pandemic treaty.

The third meeting of the National Nursing Workforce Strategy Steering Committee (SSC) was held on 6 December 2023.

An information sheet with guidance about environmental cleaning and disinfection principles for health facilities and residential aged care homes for coronavirus (COVID-19).

The 2023 Australian Influenza Surveillance Report (AISR) provides a national influenza season summary. It includes information about influenza activity, severity, impact, at-risk populations, virology, and vaccine effectiveness.

The draft of the Prescribed List Guide will provide sponsors with assistance in preparing their applications for the July 2024 Prescribed List. Stakeholders should keep in mind that this is a draft only that will be further amended and edited.

This report, and accompanying table, provide a fortnightly summary on notifications of Australia's nationally notifiable diseases for 27 November 2023 to 10 December 2023.

This fact sheet explains what happens to support residents when a residential aged care home is closing.

Health professionals can use this advice to consider whether their patients are eligible for subsidised nicotine replacement therapies under the Pharmaceutical Benefits Scheme.